April 28-30, 2026 | Rome Cavalieri

VERIGRAFT

Petter Bjorquist, Ph.D., CEO

April 29 | 10:00am | Salone dei Cavalieri, Section 1

Gothenburg, Sweden

(Private)

VERIGRAFT is at the forefront of personalized tissue therapies, bringing a paradigm shift to the treatment of serious disease. By harnessing natural, tissue-engineered grafts, VERIGRAFT offers a groundbreaking approach to restore and regenerate damaged vascular and other structures. This innovation provides patients with severe and debilitating vascular conditions access to customized, life-changing treatment options that were previously unattainable, transforming the possibilities in personalized medicine and paving the way for a new era in advanced therapeutic solutions.

www.verigraft.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions